|
|
|
|
| LEADER |
05309nam a2200565 4500 |
| 001 |
on1027173280 |
| 003 |
OCoLC |
| 005 |
20200326101151.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
180303s2018 cau o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d N$T
|d OPELS
|d NLE
|d GZM
|d OCLCF
|d YDX
|d OCLCQ
|d UPM
|d D6H
|d MYG
|d OCLCQ
|d UKMGB
|d OCLCQ
|d GrThAP
|
| 015 |
|
|
|a GBB837530
|2 bnb
|
| 016 |
7 |
|
|a 018757379
|2 Uk
|
| 019 |
|
|
|a 1027143021
|a 1027612475
|a 1027715782
|
| 020 |
|
|
|a 9780128157732
|q (electronic bk.)
|
| 020 |
|
|
|a 0128157739
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128157725
|
| 035 |
|
|
|a (OCoLC)1027173280
|z (OCoLC)1027143021
|z (OCoLC)1027612475
|z (OCoLC)1027715782
|
| 050 |
|
4 |
|a TP248.25.B53
|
| 072 |
|
7 |
|a SCI
|x 013060
|2 bisacsh
|
| 072 |
|
7 |
|a TEC
|x 009010
|2 bisacsh
|
| 082 |
0 |
4 |
|a 660
|2 23
|
| 245 |
0 |
0 |
|a Advances in Biomembranes and Lipid Self-Assembly.
|n Volume 27 /
|c edited by Aleš Iglič, Michael Rappolt, Ana J. García-Sáez.
|
| 264 |
|
1 |
|a San Diego :
|b Elsevier Science,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (264 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
0 |
|
|a Advances in Biomembranes and Lipid Self-Assembly ;
|v Volume 27
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; Advances in Biomembranes and Lipid Self-Assembly; Copyright; Contents; Contributors; Preface; Chapter One: The Role of Self-Assembling Lipid Molecules in Vaccination; 1. Introduction; 2. Immune Response to Lipids; 2.1. Innate Immune Response to Lipids; 2.2. Lipid-Stimulated PRRs (TLR4); 2.3. TLR4 Signaling; 3. Lipids, Lipid Derivatives, and Lipid Mimetics as Vaccine Adjuvants; 3.1. TLR4-Directed Vaccine Adjuvants Beyond Lipid A; 3.2. Lipid A Derivatives as Vaccine Adjuvants; 3.3. Small Molecule TLR4 Adjuvants; 3.4. Challenges With Animal Models for TLR4 Adjuvant Development.
|
| 505 |
8 |
|
|a 4. Lipid-Based Self-Assembling Vesicle as Vaccine Platforms4.1. Lipid-Based Nanovesicles as Vaccine Platforms; 4.2. Liposomes as Vaccine Platforms; 4.3. Liposome Antigens and Adjuvants; 4.4. VLPs-Based Vaccines; 4.4.1. Icosahedral and Spherical VLPs; 4.4.2. Filamentous VLPs; 4.5. Utilizing VLPs in the Context of a Highly Pathogenic Virus Research; 4.5.1. Entry; 4.5.2. Budding; References; Further Reading; Chapter Two: The Role of Mitochondrial Outer Membrane Permeabilization (MOMP) in Apoptosis: Studying Bax Pores by Cryo-El ... ; 1. Introduction; 2. In Vitro Reconstitution of MOMP (Fig. 1).
|
| 505 |
8 |
|
|a 2.1. Outer Membrane Vesicles2.2. Liposomes; 3. Bax Pores Revealed in Liposomes and OMVs by Cryo-Electron Microscopy; 3.1. Freezing Optimization; 3.2. Bax Pores in Liposomes; 3.3. Bax Pores in OMVs; 4. Bax Localization in the Pore; 4.1. Direct and Indirect Labeling of Bax With Nanogold; 4.1.1. Direct Labeling of Bax; 4.1.2. Indirect Labeling of Bax; 4.2. Bax Localization on the Pore Edges; 4.3. Bax Pores in Apoptotic Mitochondria; 5. Possible Pore Formation Mechanisms; 5.1. Bax/Bak Dimer/Oligomer Formation During MOMP; 5.2. Role for a Single Bax Molecule in Pore Formation?
|
| 505 |
8 |
|
|a 5.3. Membrane Permeabilization Induced by Antimicrobial Peptides6. Summary and Future Directions; Acknowledgments; References; Chapter Three: Electrochemical Biosensor Based on TiO2 Nanomaterials for Cancer Diagnostics; 1. Introduction; 2. Cancer; 2.1. Pathology; 2.2. Cancer Diagnostic: Current Issues; 3. Toward Novel Methods of Cancer Diagnosis; 3.1. Biosensor; 3.1.1. Molecular Recognition Element in Biosensor; 3.1.2. Transducers in Biosensor; 3.2. Electrochemical Biosensor and Electrochemical Detection Techniques; 3.2.1. Voltammetric/Amperometric Biosensors; 3.2.2. Impedimetric Biosensors.
|
| 505 |
8 |
|
|a 3.2.3. Conductometric and Capacitive Biosensors3.2.4. Potentiometric Biosensors; 3.2.5. Field Effect Transistor (FET)-Based Biosensors; 4. Nanosized Materials; 4.1. TiO2 Nanomaterials in Biomedicine; 4.2. Important Characteristics of TiO2 Nanomaterials for Biosensor Applications; 4.2.1. Specific Surface Area; 4.2.2. Wettability; 4.3. Interactions TiO2 Nanomaterials: Biological Material; 4.3.1. Effect of Gaseous Plasma Surface Treatment; 4.3.2. Effect of Electron Transfer Rate; 5. TiO2 Biosensors; 5.1. TiO2 Biosensors for Human Cancer Detection; 6. Conclusions; References; Further Reading.
|
| 500 |
|
|
|a Chapter Four: How Can Artificial Lipid Models Mimic the Complexity of Molecule-Membrane Interactions?
|
| 650 |
|
0 |
|a Bilayer lipid membranes
|x Biotechnology
|v Periodicals.
|
| 650 |
|
0 |
|a Liposomes
|v Periodicals.
|
| 650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Industrial & Technical.
|2 bisacsh
|
| 650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Chemical & Biochemical.
|2 bisacsh
|
| 650 |
|
7 |
|a Bilayer lipid membranes
|x Biotechnology.
|2 fast
|0 (OCoLC)fst00831684
|
| 650 |
|
7 |
|a Liposomes.
|2 fast
|0 (OCoLC)fst00999411
|
| 655 |
|
4 |
|a Electronic books.
|
| 655 |
|
7 |
|a Periodicals.
|2 fast
|0 (OCoLC)fst01411641
|
| 700 |
1 |
|
|a Iglič, Aleš,
|e editor.
|
| 700 |
1 |
|
|a Rappolt, Michael,
|e editor.
|
| 700 |
1 |
|
|a Garcia-Saez, Ana,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|a Iglic, Ales.
|t Advances in Biomembranes and Lipid Self-Assembly.
|d San Diego : Elsevier Science, ©2018
|z 9780128157725
|
| 856 |
4 |
0 |
|3 ScienceDirect
|u https://www.sciencedirect.com/science/bookseries/24519634/27
|z Full Text via HEAL-Link
|
